1640 related articles for article (PubMed ID: 33907845)
41. [Corrigendum] SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis
Chen F; Lu Z; Deng J; Han X; Bai J; Liu Q; Xi Y; Zheng J
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35383860
[TBL] [Abstract][Full Text] [Related]
42. [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins.
Račkauskas R; Zhou D; Ūselis S; Strupas K; Herr I; Schemmer P
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37830166
[TBL] [Abstract][Full Text] [Related]
43. [Corrigendum] MicroRNA‑379‑5p plays a tumor‑suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
Wu D; Niu X; Tao J; Li P; Lu Q; Xu A; Chen W; Wang Z
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36129145
[TBL] [Abstract][Full Text] [Related]
44. [Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.
Wu H; Li X; Feng M; Yao L; Deng Z; Zao G; Zhou Y; Chen S; Du Z
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35616168
[TBL] [Abstract][Full Text] [Related]
45. [Corrigendum] Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35674160
[TBL] [Abstract][Full Text] [Related]
46. [Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.
Li M; Xia M; Zhang Z; Tan Y; Li E; Guo Z; Fang M; Zhu Y; Hu Z
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503727
[TBL] [Abstract][Full Text] [Related]
47. [Corrigendum] MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2.
Mu L; Guan B; Tian J; Li X; Long Q; Wang M; Wang W; She J; Li X; Wu D; Du Y
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36102314
[TBL] [Abstract][Full Text] [Related]
48. [Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981815
[TBL] [Abstract][Full Text] [Related]
49. [Corrigendum] Cyclophilin D modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol.
Tian W; Xu D; Han W; He H; Cai H; Chen H; Zhou M; Chen J; Deng YC
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955504
[TBL] [Abstract][Full Text] [Related]
50. [Corrigendum] BCL‑3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36484414
[TBL] [Abstract][Full Text] [Related]
51. [Corrigendum] MicroRNA‑338 inhibits migration and proliferation by targeting hypoxia‑induced factor 1α in nasopharyngeal carcinoma.
Shan Y; Li X; You B; Shi S; Zhang Q; You Y
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35762326
[TBL] [Abstract][Full Text] [Related]
52. [Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866758
[TBL] [Abstract][Full Text] [Related]
53. [Corrigendum] Role of Thrombospondin‑1 in sepsis‑induced myocardial injury.
Xie Y; Zhang J; Jin W; Tian R; Wang R
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37083065
[TBL] [Abstract][Full Text] [Related]
54. [Corrigendum] The novel anti‑neuroblastoma agent PF403, inhibits proliferation and invasion
Li C; Li Y; Lv H; Li S; Tang K; Zhou W; Yu S; Chen X
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069224
[TBL] [Abstract][Full Text] [Related]
55. [Corrigendum] Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Song H; Dong M; Zhou J; Sheng W; Li X; Gao W
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069219
[TBL] [Abstract][Full Text] [Related]
56. [Corrigendum] miRNA‑183‑5p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1.
Lin J; Shen J; Yue H; Cao Z
Oncol Rep; 2021 Feb; 45(2):789-790. PubMed ID: 33416187
[TBL] [Abstract][Full Text] [Related]
57. [Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 34981822
[TBL] [Abstract][Full Text] [Related]
58. [Corrigendum] FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β‑catenin nuclear accumulation.
Xu K; Zhang Z; Pei H; Wang H; Li L; Xia Q
Oncol Rep; 2021 Jan; 45(1):403. PubMed ID: 33169799
[TBL] [Abstract][Full Text] [Related]
59. [Corrigendum] MicroRNA‑218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.
Wang T; Chen T; Niu H; Li C; Xu C; Li Y; Huang R; Zhao J; Wu S
Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37350403
[TBL] [Abstract][Full Text] [Related]
60. [Corrigendum] miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
Zhou H; Gan M; Jin X; Dai M; Wang Y; Lei Y; Lin Z; Ming J
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36331032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
